Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

CHICAGO (WLS) -- Football players are among the professional athletes at highest risk for developing a neurodegenerative disease known as CTE. Currently, it can only be identified during an autopsy, ...

There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs that ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Many high schools for years have maintained two separate tracks for students: the college-bound path for students who took traditional academic classes and the “vo-tech” path for kids who spent at ...

EdSource · When teens counsel teens: Why peer support programs are growing On a 40-degree December day in the Central Valley, two dozen high school students in firefighter gear steady themselves ...

Black students enroll in career and technical education programs at rates on par with their peers, but studies suggest they’re overrepresented in service-oriented fields that lead to lower-wage jobs, ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...